Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Breast 2

Conditions

Breast Neoplasms 2Brain Neoplasms 2Meningioma 1

Interventions

pembrolizumab 1254Specimen Handling 869Carboplatin 818Magnetic Resonance Spectroscopy 804Cyclophosphamide 795Cisplatin 716Nivolumab 648Paclitaxel 623Radiotherapy 567Gemcitabine 565Biopsy 529Bevacizumab 468Dexamethasone 434fludarabine 404Docetaxel 373venetoclax 366Oxaliplatin 362Capecitabine 353Fluorouracil 352atezolizumab 341Rituximab 327durvalumab 326Doxorubicin 313Radiosurgery 306Pemetrexed 303Drug Therapy 295Standard of Care 292Ipilimumab 290Etoposide 280Radiation 278

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Neuroimaging × 1 year × Clear all
NCT06377371 2026-02-27

Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

Weill Medical College of Cornell University

Phase 4 Recruiting
20 enrolled
CNS

Meningioma

NCT06247449 2025-12-18

MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer

Sunnybrook Health Sciences Centre

Phase NA Recruiting
100 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT06072807 2025-11-24

Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer

Weill Medical College of Cornell University

Phase 4 Recruiting
20 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡